<DOC>
	<DOCNO>NCT01745770</DOCNO>
	<brief_summary>The purpose trial proof whether TID 1000 mg mesalazine non-inferior TID 2x 500 mg mesalazine treatment patient acute ulcerative colitis</brief_summary>
	<brief_title>TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine Active Ulcerative Colitis ( UC )</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Signed informed consent Men woman age 18 75 year Active ulcerative colitis , except proctitis limit 15 cm ab ano , confirm endoscopy histology Crohn 's disease , indeterminate colitis , ischemic colitis , radiation colitis , diverticular disease associate colitis , microscopic colitis ( i.e. , collagenous colitis lymphocytic colitis ) Toxic megacolon Screening stool positive germ cause bowel disease Malabsorption syndromes Celiac disease Other inflammatory bleed disorder colon intestine , disease may cause diarrhoea gastrointestinal bleeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>